Studying early risk signs for multiple sclerosis
Treatments studied
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study looks at people who are at higher risk for multiple sclerosis (MS), to better understand early changes before MS is diagnosed. It may help doctors identify who is more likely to develop MS and how to monitor them sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have at least one MS risk factor, such as a past ‘radiologically isolated syndrome’ result, MS in a first-degree relative, or personal risk factors (like smoking or obesity)
- Not be pregnant
- Not already have an MS diagnosis
- Not have any ongoing whole-body (systemic) autoimmune disease
- Not be taking medications that suppress the immune system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how genes and life exposures may relate to developing multiple sclerosis (MS) or to MS itself. You may be invited if you have a specific connection to MS or certain past immune-related treatments.
This study looks at “subclinical markers,” meaning early or hidden body changes that may show how relapsing-remitting multiple sclerosis (MS) is doing even when symptoms seem mild. It may help researchers find better ways to monitor MS and detect changes sooner.
This study looks at genetic information and blood test signals to understand why some people with early MS develop a worse outcome. It may help doctors predict who is at higher risk and better understand disease mechanisms.
This study follows people with multiple sclerosis over time to learn more about the disease and improve care. If you join, you will help researchers understand MS better, which could lead to better treatments.
This study looks at different immune cells in blood and, sometimes, spinal fluid (CSF) to understand what’s driving multiple sclerosis (MS) or early MS-like symptoms. Your participation may help researchers better explain the disease and potentially improve how it’s diagnosed or treated.
This study looks at people with relapsing-remitting multiple sclerosis (RRMS) to find factors that predict disability progression even when they are not having relapses. It may help doctors understand who is at higher risk and guide treatment decisions.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.